A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
CMS Develops Additional Code for Coronavirus Lab Tests
...
Already a member? Log in here
Top of the News: CMS Issues New Guidance for Laboratories Performing Coronavirus Testing
On Feb. 4, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) clearance for the first test approved in the US for detecting the novel coronavirus. Developed by the US Centers for Disease Control and Prevention (CDC) using sequencing...
Point of Care: Is the Blood-Drawing Robot the Phlebotomist of the Future?
...
Already a member? Log in here
FDA Watch: Agency Grants Emergency Clearance for CDC Novel Coronavirus Detection Test
...
Already a member? Log in here
Strategic planning needs to evolve over time
...
Already a member? Log in here
Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
Already a member? Log in here
Lab Companies Scramble to Bring Coronavirus Detection Tests to Market
...
Already a member? Log in here
Doing What We’ve Always Done
...
Already a member? Log in here
Test Quality: New Study Casts Doubt on Whole Exome Sequencing’s Accuracy in Diagnosing Genetic Disorders
Depending on the reporting laboratory, patients who undergo whole exome sequencing may receive false negatives or incomplete test results. That is the finding of a new study published in Clinical Chemistry
